PDCD1LG2 and renal cell carcinoma: This may indicate that PD-L1+ RCC tumors [104] or PD-L1+PD-L2+ RCC tumors [83] promote immunosuppression, in part by directly activating PD-1 on innate myeloid and lymphoid immune cells.